PlainRecalls
FDA Drug Moderate Class II Terminated

MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.

Reported: January 29, 2014 Initiated: July 2, 2013 #D-877-2014

Product Description

MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.

Reason for Recall

Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.

Details

Recalling Firm
Aidapak Services, LLC
Units Affected
100 Tablets
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Location
Vancouver, WA

Frequently Asked Questions

What product was recalled?
MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.. Recalled by Aidapak Services, LLC. Units affected: 100 Tablets.
Why was this product recalled?
Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 29, 2014. Severity: Moderate. Recall number: D-877-2014.